OBJECTIVE: Currently, there is no adult-specific decision aid (DA) to support decision-making regarding recurrent tonsillitis. This study intends to address this gap by piloting a prototype DA. DESIGN: Randomised clinical trial. SETTING: Single centre trial at a tertiary otolaryngology department. PARTICIPANTS: Forty-three patients were randomised to either the DA or Treatment as Usual (TAU) group. MAIN OUTCOME MEASURES: Primary objective: To measure how patients rate the quality of their decision-making experience at the time of the decision and at follow-up (SURE scale). SECONDARY OBJECTIVE: The level of decisional satisfaction at the time of the decision and follow-up, as well as to explore the numbers of people opting for surgery for each study condition (Shared tool and patient feedback). RESULTS: Quality: This study demonstrates no statistically significant difference in how patients rate the quality of their treatment decision between DA and TAU, both at baseline (p = 0.553) and follow-up (p = 0.062). Satisfaction: This study showed a statistically significant level of decisional satisfaction at the time the decision was made for Qu2 of the Shared tool (U = 113, p = 0.026). No other significant difference was found between participants who received the DA and TAU. CONCLUSION: The DA is an acceptable and useful tool that could be incorporated into the pathway for recurrent tonsillitis, helping to eliminate physician implicit bias. However, preliminary qualitative evidence from this pilot study does not suggest that including the DA improves the quality of decision-making. TRIAL REGISTRATION: IRAS ID - 230 362.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.